S.Korea in talks with mRNA vaccine makers to make up to 1 billion doses

SEOUL (Reuters): South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce Covid-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said.

The plan, if agreed, would help ease tight global supply of Covid-19 vaccines, particularly in Asia which lags North America and Europe in vaccine rollouts, and put South Korea a step closer to its ambition to become a major vaccine manufacturing centre.